biotech · Atopic Dermatitis · Asthma · APGE
Apogee Therapeutics
Apogee Therapeutics is a biotech organization headquartered in WALTHAM, MA, USA. It trades on NYSE under ticker APGE. Primary therapeutic focus areas include Atopic Dermatitis, Asthma, Carcinoma, Hepatocellular, Diffuse
WALTHAM, MA, USA HQ
2022 Founded
293 Employees
Public company Type
APGE · NYSE Ticker
Company details
- Status
- Public
- HQ
- WALTHAM, MA, USA
- Founded
- 2022
- Employees
- 293
- Programs
- 8
- Drugs
- 2
- Patents
- 7
sphingosine kinase-2 inhibitor ABC294640
Phase 1 · small molecule · Pancreatic Cancer
sphingosine kinase-2 inhibitor ABC294640 for Pancreatic Cancer is a Phase 1 program (small_molecule) at Apogee Therapeutics with 1 ClinicalTrials.gov record(s).
Internal code CTO 101504
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Apogee Therapeutics
- Phase
- Phase 1
- Modality
- small_molecule
- Indication
- Pancreatic Cancer
- Status
- completed
- Trials
- 1